Needle Free Injection Market: By Product, Source of Power, Type, Site of Delivery, Application, and End User and Region Forecast 2019-2030

Needle Free Injection Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Fillable and Prefilled), Source of Power (Spring-based Injector Systems and Gas Propelled/Air Forced Injector Systems), Type (Liquid-based, Projectile/Depot-based, and Powder-based), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, and Pain Management), and End User (Hospitals & Clinics, Home Care Settings, and Research Laboratories) and Region Forecast 2019-2030

Needle Free Injection Market size was valued at US$ 125 million in 2023 and is poised to grow at a CAGR of 17.2% from 2024-2030. Due to the increase in prevalence of various types of chronic diseases such as cancer, diabetes and so on, risk of exposure to communicable diseases due to needle stick injuries, and decrease in healthcare costs. Moreover, the advantage of painlessness, the wide range of applications with the needle-free injection, and the rise in R&D activities for the development of needle-free injections are the major factors that are driving the growth of the global market over the forecast timeframe.

This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global needle free injection products.

Global Needle Free Injection Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

17.2%

Largest Market

North America

Fastest Growing Market

Europe

Needle Free Injection Market Dynamics

Increase in the prevalence of cancer, diabetes, and infectious diseases is a key factor drive the global needle free injection market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe and approximately 422 Mn people are suffering from diabetes all over the world. Moreover, the raise in funding for the R&D activities by public and private sectors and the wide range of applications and advantages are anticipated to propel the global needle free injection market over the forecast years.

Global Needle Free Injection Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 125 million

Market CAGR

17.2%

By Type of Medication

  • Liquid-Based Needle Free Injectors
  • Projectile/Depot-Based Needle-Free Injectors
  • Powder-Based Needle Free Injectors

By Product

  • Prefilled Needle-Free Injectors
  • Fillable Needle-Free Injectors

By Application

  • Vaccine Delivery
  • Insulin Delivery
  • Pain Management
  • Other Applications

By End User

  • Hospitals & Clinics
  • Home Care Settings
  • Research laboratories
  • Others

Key Features of the Report

  • The needle free injection market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The needle free injection market size was valued at US$ 125 million in 2023. and is projected to grow at a CAGR of 17.2% from 2024 to 2030.

The needle-free injection market: Antares Pharma, (U.S.) Crossject needle-free injection systems ( France) DAntonio Consultants International Inc. (U.S.) European Pharma Group (Netherlands) Endo Pharmaceuticals Inc. (Ireland) INJEX Pharma GmBH. (Germany) Medical International Technology, Inc., (Canada) National Medical Products Inc., (Saudi Arabia) Mika Medical Co., (Korea) PenJet Corporation. (U.S.)

The needle-free injection market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Needle Free Injection Market Introduction 
2.1.Global Needle Free Injection Market  - Taxonomy
2.2.Global Needle Free Injection Market  - Definitions
2.2.1.Type of Medication
2.2.2.Product
2.2.3.Application
2.2.4.Region
3. Global Needle Free Injection Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Needle Free Injection Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Needle Free Injection Market  By Type of Medication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Liquid-Based Needle Free Injectors
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Projectile/Depot-Based Needle-Free Injectors
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Powder-Based Needle Free Injectors
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Needle Free Injection Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Prefilled Needle-Free Injectors
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Fillable Needle-Free Injectors
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Needle Free Injection Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Vaccine Delivery
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Insulin Delivery
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Pain Management
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Other Applications
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Needle Free Injection Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type of Medication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Liquid-Based Needle Free Injectors
9.1.2.Projectile/Depot-Based Needle-Free Injectors
9.1.3.Powder-Based Needle Free Injectors
9.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Prefilled Needle-Free Injectors
9.2.2.Fillable Needle-Free Injectors
9.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Vaccine Delivery
9.3.2.Insulin Delivery
9.3.3.Pain Management
9.3.4.Other Applications
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Needle Free Injection Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type of Medication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Liquid-Based Needle Free Injectors
10.1.2.Projectile/Depot-Based Needle-Free Injectors
10.1.3.Powder-Based Needle Free Injectors
10.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Prefilled Needle-Free Injectors
10.2.2.Fillable Needle-Free Injectors
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Vaccine Delivery
10.3.2.Insulin Delivery
10.3.3.Pain Management
10.3.4.Other Applications
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type of Medication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Liquid-Based Needle Free Injectors
11.1.2.Projectile/Depot-Based Needle-Free Injectors
11.1.3.Powder-Based Needle Free Injectors
11.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Prefilled Needle-Free Injectors
11.2.2.Fillable Needle-Free Injectors
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Vaccine Delivery
11.3.2.Insulin Delivery
11.3.3.Pain Management
11.3.4.Other Applications
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type of Medication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Liquid-Based Needle Free Injectors
12.1.2.Projectile/Depot-Based Needle-Free Injectors
12.1.3.Powder-Based Needle Free Injectors
12.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Prefilled Needle-Free Injectors
12.2.2.Fillable Needle-Free Injectors
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Vaccine Delivery
12.3.2.Insulin Delivery
12.3.3.Pain Management
12.3.4.Other Applications
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type of Medication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Liquid-Based Needle Free Injectors
13.1.2.Projectile/Depot-Based Needle-Free Injectors
13.1.3.Powder-Based Needle Free Injectors
13.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Prefilled Needle-Free Injectors
13.2.2.Fillable Needle-Free Injectors
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Vaccine Delivery
13.3.2.Insulin Delivery
13.3.3.Pain Management
13.3.4.Other Applications
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Antares Pharma, , (U.S.)
14.2.2.Crossject needle-free injection systems ( France)
14.2.3.DAntonio Consultants International Inc. (U.S.)
14.2.4.European Pharma Group (Netherlands)
14.2.5.Endo Pharmaceuticals Inc. (Ireland)
14.2.6.INJEX Pharma GmBH. (Germany)
14.2.7.Medical International Technology, Inc., (Canada)
14.2.8.National Medical Products Inc., (Saudi Arabia)
14.2.9.Mika Medical Co., (Korea)
14.2.10.PenJet Corporation. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Antares Pharma, , (U.S.)
  • Crossject needle-free injection systems ( France)
  • DAntonio Consultants International Inc. (U.S.)
  • European Pharma Group (Netherlands)
  • Endo Pharmaceuticals Inc. (Ireland)
  • INJEX Pharma GmBH. (Germany)
  • Medical International Technology, Inc., (Canada)
  • National Medical Products Inc., (Saudi Arabia)
  • Mika Medical Co., (Korea)
  • PenJet Corporation. (U.S.)

Related Industry Reports